Copeland Capital Management, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1541743
Conshohocken, PA
Position in REGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$845,520
-$274,035 QoQ
Shares Held
1,356
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#677
of 1,322 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Copeland Capital Management, LLC holds $845,520 across 1 Biotechnology name. REGN ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,356 | $845,520 |
All Filings in REGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $845,520 | 1,356 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $1,119,555 | 1,449 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,108,405 | 1,436 | Shares | Sole | 2026-01-29 | |
| No filing history on record for this holder in this stock. | ||||||